Ms. Susanna High's most recent trade in Dyne Therapeutics Inc was a trade of 4,636 Common Stock done at an average price of $34.4 . Disclosure was reported to the exchange on Sept. 18, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 34.41 per share. | 18 Sep 2024 | 4,636 | 131,636 | - | 34.4 | 159,525 | Common Stock |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 34.41 per share. | 18 Sep 2024 | 4,340 | 136,272 | - | 34.4 | 149,339 | Common Stock |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 31.89 per share. | 11 Sep 2024 | 2,722 | 140,612 | - | 31.9 | 86,805 | Common Stock |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 31.89 per share. | 11 Sep 2024 | 2,548 | 143,334 | - | 31.9 | 81,256 | Common Stock |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 45.01 per share. | 19 Aug 2024 | 2,582 | 146,210 | - | 45.0 | 116,216 | - |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 46.00 per share. | 19 Aug 2024 | 328 | 145,882 | - | 46 | 15,088 | - |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 21 Jun 2024 | 29,787 | 178,579 | - | 5.5 | 165,020 | Common Stock |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | 21 Jun 2024 | 29,787 | 70,699 | - | - | Stock option (right to buy) | ||
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 35.01 per share. | 21 Jun 2024 | 29,787 | 148,792 | - | 35.0 | 1,042,843 | Common Stock |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 21 Jun 2024 | 29,787 | 178,579 | - | 5.5 | 165,020 | - |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 35.01 per share. | 21 Jun 2024 | 29,787 | 148,792 | - | 35.0 | 1,042,843 | - |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 35.33 per share. | 21 Jun 2024 | 10,213 | 148,792 | - | 35.3 | 360,825 | - |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 21 Jun 2024 | 10,213 | 159,005 | - | 5.5 | 56,580 | - |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | 21 Jun 2024 | 10,163 | 60,536 | - | - | Stock option (right to buy) | ||
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 35.33 per share. | 21 Jun 2024 | 10,163 | 148,792 | - | 35.3 | 359,059 | Common Stock |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 21 Jun 2024 | 10,163 | 158,955 | - | 5.5 | 56,303 | Common Stock |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 12 Jun 2024 | 40,000 | 188,792 | - | 5.5 | 221,600 | - |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 33.17 per share. | 12 Jun 2024 | 26,036 | 162,756 | - | 33.2 | 863,614 | - |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 33.70 per share. | 12 Jun 2024 | 13,964 | 148,792 | - | 33.7 | 470,587 | - |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 10 Jun 2024 | 80,000 | 234,062 | - | 5.5 | 443,200 | - |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.24 per share. | 10 Jun 2024 | 80,000 | 154,062 | - | 30.2 | 2,419,200 | - |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 31.23 per share. | 10 Jun 2024 | 2,913 | 148,792 | - | 31.2 | 90,973 | - |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 31.23 per share. | 10 Jun 2024 | 2,357 | 151,705 | - | 31.2 | 73,609 | - |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 28.20 per share. | 16 May 2024 | 2,249 | 154,551 | - | 28.2 | 63,422 | - |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 28.59 per share. | 16 May 2024 | 489 | 154,062 | - | 28.6 | 13,981 | - |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 26.66 per share. | 08 Mar 2024 | 26,908 | 159,383 | - | 26.7 | 717,367 | - |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 25.70 per share. | 08 Mar 2024 | 2,292 | 156,800 | - | 25.7 | 58,904 | - |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 27.41 per share. | 08 Mar 2024 | 291 | 159,092 | - | 27.4 | 7,976 | - |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 25.85 per share. | 07 Mar 2024 | 1,591 | 186,291 | - | 25.8 | 41,127 | - |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.72 per share. | 11 Dec 2023 | 1,616 | 187,882 | - | 10.7 | 17,324 | Common Stock |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 94,893 | 189,498 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | 15 Nov 2023 | 36,952 | 36,952 | - | - | Stock Option (right to buy) | ||
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.40 per share. | 02 Nov 2023 | 9,939 | 94,605 | - | 7.4 | 73,549 | Common Stock |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 9.41 per share. | 18 Sep 2023 | 2,672 | 104,544 | - | 9.4 | 25,144 | Common Stock |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.41 per share. | 12 Sep 2023 | 1,635 | 107,216 | - | 10.4 | 17,020 | Common Stock |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 12.43 per share. | 13 Jun 2023 | 1,625 | 108,851 | - | 12.4 | 20,199 | Common Stock |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 13.33 per share. | 14 Mar 2023 | 1,559 | 110,476 | - | 13.3 | 20,781 | Common Stock |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | 09 Dec 2022 | 69,000 | 69,000 | - | - | Stock Option (right to buy) | ||
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 44,000 | 112,786 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.87 per share. | 09 Dec 2022 | 751 | 112,035 | - | 10.9 | 8,163 | Common Stock |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 13.70 per share. | 20 Sep 2022 | 2,629 | 68,786 | - | 13.7 | 36,017 | Common Stock |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 14.05 per share. | 15 Sep 2022 | 786 | 71,415 | - | 14.0 | 11,043 | Common Stock |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | 05 Jul 2022 | 36,219 | 36,219 | - | - | Stock Option (right to buy) | ||
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 4.95 per share. | 14 Jun 2022 | 802 | 72,201 | - | 5.0 | 3,970 | Common Stock |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.73 per share. | 11 Mar 2022 | 765 | 73,003 | - | 8.7 | 6,678 | Common Stock |
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | 10 Dec 2021 | 60,472 | 60,472 | - | - | Stock Option (right to buy) | ||
| Dyne Therapeutics Inc | Ms. Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 40,315 | 73,768 | - | 0 | Common Stock |